` VICO (Vicore Pharma Holding AB) vs OMX Stockholm 30 Comparison - Alpha Spread

VICO
vs
O
OMX Stockholm 30

Over the past 12 months, VICO has outperformed OMX Stockholm 30, delivering a return of +29% compared to the OMX Stockholm 30's +11% growth.

Stocks Performance
VICO vs OMX Stockholm 30

Loading
VICO
OMX Stockholm 30
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
VICO vs OMX Stockholm 30

Loading
VICO
OMX Stockholm 30
Difference
www.alphaspread.com

Performance By Year
VICO vs OMX Stockholm 30

Loading
VICO
OMX Stockholm 30
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Competitors Performance
Vicore Pharma Holding AB vs Peers

OMX Stockholm 30
VICO
ABBV
AMGN
GILD
VRTX
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Vicore Pharma Holding AB
Glance View

Market Cap
2.8B SEK
Industry
Biotechnology

Vicore Pharma Holding AB is a pharmaceutical company, which engages in the development of drugs with focus on interstitial lung diseases and related indications. The company is headquartered in Goeteborg, Vastra Gotalands. The company went IPO on 2015-12-10. The firm's portfolio contains small molecules with potential indications, including anti-inflammation, nerve generation and cardiovascular disease. The firm is a wholly owned subsidiary of Mintage Scientific AB.

VICO Intrinsic Value
1.96 SEK
Overvaluation 80%
Intrinsic Value
Price
Back to Top